Semax (30mg)

Semax, a synthetic derivative of adrenocorticotrophic hormone, has emerged as a multifaceted peptide with potential benefits across various physiological domains. Originating from Russia, Semax has been investigated for its diverse therapeutic properties. Research suggests that Semax may play a role in enhancing immune function, providing neuroprotection, and promoting cardiovascular well-being.

Its potential applications extend to pain management and blood clotting regulation, making it a peptide of interest in various medical contexts.

In clinical studies, Semax has demonstrated promise in conditions cognitive decline or impairment and optic nerve inflammation. Moreover, its immunomodulatory effects and the observed antidepressant and anxiolytic properties contribute to its growing recognition. Semax’s influence on the central nervous system is notable, as it has been shown to elevate levels of brain-derived neurotrophic factor (BDNF), serotonin, and dopamine.

The multifaceted nature of Semax, coupled with its potential to modulate various neurotransmitters and immune responses, positions it as a subject of ongoing research for its therapeutic applications.

Products are lyophilized in powder form.